CD8A and neoplasm: However, combined with an immune checkpoint inhibitor, Tim-4 blockade significantly slowed tumor progression, proposing the treatment strategy that blockade of Tim-4-mediated sequestration against phosphatidylserine+CD8+ T cells to enhance the efficacy of CD8+ T cell-based immunotherapies (80).